Table 2 Impact of clinicopathological parameters on OS in DLBCL
Total (n = 71) | Number of events | P value | |
|---|---|---|---|
Sex | 0.219 | ||
Men Women | 38 33 | 16 10 | |
Extranodal involvement | 0.068 | ||
Yes No | 53 18 | 23 3 | |
Stage | 0.520 | ||
I–II III–IV | 18 53 | 8 18 | |
Elevated LDHb | 0.210 | ||
Yes No | 51 17 | 16 8 | |
B symptomsb | 0.149 | ||
Yes No | 20 49 | 10 15 | |
IPI scoreb | 0.431 | ||
0–2 3–5 | 26 42 | 8 16 | |
Performance scorea | 0.114 | ||
0–2 3–4 | 62 9 | 21 5 | |
Responseb | 0.061 | ||
CR PD/PR | 51 10 | 14 5 | |
Age at diagnosis | 0.059 | ||
<60 years ≥60 years | 30 41 | 7 19 | |
Rituximabb | 0.782 | ||
Yes No | 59 11 | 21 4 |